Total Payments
$15,391
2024 Payments
$1,323
Companies
28
Transactions
240
Medicare Patients
6,063
Medicare Billing
$892,211
Payment Breakdown by Category
Food & Beverage$15,322 (99.6%)
Education$68.27 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,322 | 230 | 99.6% |
| Education | $68.27 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $4,094 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,583 | 22 | $0 (2024) |
| Amgen Inc. | $2,519 | 37 | $0 (2024) |
| PFIZER INC. | $1,085 | 25 | $0 (2023) |
| Esperion Therapeutics, Inc. | $974.13 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $865.31 | 15 | $0 (2020) |
| GlaxoSmithKline, LLC. | $664.57 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $503.67 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $271.55 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $232.91 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,323 | 16 | AstraZeneca Pharmaceuticals LP ($592.74) |
| 2023 | $1,892 | 24 | Janssen Pharmaceuticals, Inc ($468.70) |
| 2022 | $1,772 | 27 | Janssen Pharmaceuticals, Inc ($547.94) |
| 2021 | $2,798 | 46 | Esperion Therapeutics, Inc. ($854.69) |
| 2020 | $1,210 | 23 | AstraZeneca Pharmaceuticals LP ($374.87) |
| 2019 | $2,482 | 45 | Janssen Pharmaceuticals, Inc ($843.67) |
| 2018 | $2,615 | 39 | Janssen Pharmaceuticals, Inc ($917.94) |
| 2017 | $1,299 | 20 | PFIZER INC. ($253.89) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $93.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $79.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $56.13 | General |
| Category: NEUROLOGY | ||||||
| 04/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 03/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Oncology | ||||||
| 12/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $114.58 | General |
| 11/07/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $120.11 | General |
| Category: VACCINES | ||||||
| 07/07/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,462 | 2,527 | $647,307 | $207,788 |
| 2022 | 10 | 1,526 | 2,363 | $590,004 | $225,517 |
| 2021 | 16 | 1,615 | 2,438 | $589,856 | $249,224 |
| 2020 | 9 | 1,460 | 2,068 | $564,085 | $209,682 |
Total Patients
6,063
Total Services
9,396
Medicare Billing
$892,211
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 315 | 756 | $114,284 | $61,178 | 53.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 317 | 324 | $188,636 | $57,126 | 30.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 157 | 158 | $55,799 | $29,132 | 52.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 87 | 345 | $78,785 | $15,341 | 19.5% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 15 | 15 | $13,500 | $10,584 | 78.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 59 | 60 | $20,900 | $10,498 | 50.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 292 | 645 | $40,355 | $8,712 | 21.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 162 | 164 | $118,895 | $8,209 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 32 | $9,115 | $3,746 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,356 | $2,170 | 64.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,682 | $1,092 | 29.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 481 | 493 | $269,444 | $92,845 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 296 | 717 | $90,678 | $58,849 | 64.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 156 | 156 | $55,610 | $30,019 | 54.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 186 | 186 | $74,880 | $10,195 | 13.6% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 54 | 54 | $19,146 | $9,929 | 51.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 294 | 644 | $50,920 | $8,618 | 16.9% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 11 | 11 | $9,900 | $7,805 | 78.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 18 | 72 | $13,320 | $3,489 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,306 | $2,821 | 65.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,800 | $947.61 | 52.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 486 | 499 | $271,501 | $96,589 | 35.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 294 | 708 | $77,946 | $56,647 | 72.7% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 155 | 156 | $56,015 | $31,056 | 55.4% |
| 93978 | Ultrasound scan of vena cava or groin graft or vessel blood flow | Office | 2021 | 60 | 63 | $22,781 | $11,958 | 52.5% |
About Dr. Mladen Solar, M.D
Dr. Mladen Solar, M.D is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780677823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mladen Solar, M.D has received a total of $15,391 in payments from pharmaceutical and medical device companies, with $1,323 received in 2024. These payments were reported across 240 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($15,322).
As a Medicare-enrolled provider, Solar has provided services to 6,063 Medicare beneficiaries, totaling 9,396 services with total Medicare billing of $892,211. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 08/24/2005
- Last Updated 12/10/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1780677823
Products in Payments
- XARELTO (Drug) $4,094
- Repatha (Biological) $2,180
- FARXIGA (Drug) $1,704
- ELIQUIS (Drug) $1,250
- NEXLIZET (Drug) $817.87
- JARDIANCE (Drug) $696.79
- BRILINTA (Drug) $510.22
- VERQUVO (Drug) $418.34
- AREXVY (Drug) $249.99
- ENTRESTO (Drug) $249.94
- LOKELMA (Drug) $249.31
- Otezla (Drug) $166.87
- SAPIEN 3 Ultra RESILIA (Device) $161.26
- NEXLETOL (Drug) $156.26
- SHINGRIX (Biological) $150.02
- AVEIR (Device) $132.62
- Austedo XR (Drug) $125.00
- Ozempic (Drug) $125.00
- TRELEGY ELLIPTA (Drug) $125.00
- Vascepa (Drug) $125.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Idan Sharon, M.d, M.D
Specialist — Payments: $2.3M
Specialist $2.3M
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Specialist $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Specialist $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Specialist $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Specialist $41,408
Dr. Madhavi Reddy, M.d, M.D
Specialist — Payments: $40,649
Specialist $40,649